Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] The global burden of liver disease
Chronic liver disease (CLD) and its associated complications (cirrhosis and liver cancer)
cause significant mortality, morbidity, and economic burden. Published data from the World …
cause significant mortality, morbidity, and economic burden. Published data from the World …
Progress towards elimination goals for viral hepatitis
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and
hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top …
hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top …
[ספר][B] Prevention of mother-to-child transmission of hepatitis B virus (HBV): Guidelines on antiviral prophylaxis in pregnancy
World Health Organization - 2020 - books.google.com
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …
[HTML][HTML] Global burden of primary liver cancer in 2020 and predictions to 2040
Background & Aims The burden of liver cancer varies across the world. Herein, we present
updated estimates of the current global burden of liver cancer (incidence and mortality) and …
updated estimates of the current global burden of liver cancer (incidence and mortality) and …
Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis
Background Prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV)
involves neonatal immunoprophylaxis, with a birth dose of hepatitis B vaccine and immune …
involves neonatal immunoprophylaxis, with a birth dose of hepatitis B vaccine and immune …
CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients
Y Tian, Z Fan, L Xu, Y Cao, S Chen, Z Pan… - Emerging Microbes & …, 2023 - Taylor & Francis
ABSTRACT Background & Aims The WHO declared to eliminate hepatitis B virus (HBV) by
2030. However, an increasing number of patients are presenting with low-level viremia …
2030. However, an increasing number of patients are presenting with low-level viremia …
Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030
Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to
occur, with an estimated global burden of 296 million individuals living with chronic hepatitis …
occur, with an estimated global burden of 296 million individuals living with chronic hepatitis …
A global investment framework for the elimination of hepatitis B
Background & Aims More than 292 million people are living with hepatitis B worldwide and
are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) …
are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) …
Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study
Background In 2020, WHO recommended the addition of peripartum antiviral prophylaxis
(PAP) to hepatitis B birth dose vaccination (HepB-BD) and hepatitis B infant vaccination …
(PAP) to hepatitis B birth dose vaccination (HepB-BD) and hepatitis B infant vaccination …
Trends of the global hepatitis C disease burden: strategies to achieve elimination
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as
for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is …
for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is …